• Krieg DeVault is proud to sponsor the 25th Anniversary of
    Indianapolis Business Journal’s Forty Under 40 Program.

    Forty Under Forty
  • A Sampling of our recent Transactions with some of our many Successful Clients.

  • Krieg DeVault provides transaction counsel to $22.9 million restoration
    and adaptive reuse of South Bend's Studebaker Innovation Center.

  • Krieg DeVault Attorneys named to 2017 Best Lawyers in America© Listing;
    Attorneys Receive Lawyer of the Year Honors.

    2017 Best Lawyers Slider
  • Krieg DeVault's Real Estate Practice helps client Kittle's Furniture
    reestablish its Indianapolis roots.

Life Sciences

PDFEmailPrint

At the intersection of health care, intellectual property, corporate law, and governmental affairs, Krieg DeVault offers creative solutions to the business needs of our life sciences clients, enabling them to turn scientific discovery into commercial success. Whether it’s help with project or enterprise funding, capital formation, intellectual property protection and counseling, business transactions and joint ventures, products liability, clinical research, and other regulatory guidance, our lawyers combine legal skill and industry knowledge for focused planning that meets the challenges facing life sciences companies today. Our lawyers have technical experience in a range of fields related to life sciences, including biology, biotechnology, chemistry, diagnostics, medical and biomedical devices, and health care administration. We also have advised on health care and business incubation policy at senior levels of government and have extensive contacts among angel and venture investors and other private equity groups. As legal and business counselors to medical device, biologics and pharmaceutical companies, and university research organizations, we can provide comprehensive guidance to emerging and established life sciences companies at every stage of their growth and development.

Services

  • Entity Formation
    • Business Formation
    • Foundations and Other Exempt Organizations
    • Executive Compensation and Incentive Programs
  • Funding and Capital Formation
    • Venture Capital and Mezzanine Financing
    • Registered Securities Offerings (IPO)
    • Private Placements
    • Bank Financing
    • Grants
    • Economic Development Incentives
    • Stimulus Bill (ARRA)
  • Business Transactions
    • Joint Ventures and Other Transactions
    • Purchases and Sales
    • Collaboration Agreements
    • Antitrust Issues
  • Asset Protection/Intellectual Property
    • Patents
    • Trademarks
    • Copyrights
    • Trade Secret Protections
    • Clearance/Freedom to Operate Opinions
    • IP Litigation
    • IP Related Agreements
      • Confidentiality/non-Disclosure Agreements
      • Joint Development
      • Licenses
      • Assignments
      • Teaming Agreements
  • Employment and Benefits
    • Executive Compensation and Incentive Programs
    • Labor and Employment
    • Employee Benefits
  • Governmental Affairs
    • Government Relations
    • Government Procurement
  • Operations
    • Real Estate
    • Tax
    • Insurance
    • Outsourcing
  • Regulatory Services
    • Licenses, Certifications and Accreditations
    • Health Care and Other Vendor Interactions
    • FDA and Other Regulatory Compliance
      • Pre-Market
      • Clinical Research
      • Production and Marketing
      • Post-Market
    • Institutional Review Board (IRB) Approvals
    • Fraud and Abuse
    • Privacy and Security of Protected Health (and Other Personal) Information
    • Pricing, Payment and Reimbursement
  • Risk Management
    • Government Investigations
    • Civil and Criminal Enforcement
    • Litigation
    • Products Liability